Date | Time | Source | Headline | Symbol | Company |
11/07/2016 | 21:23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
11/07/2016 | 17:10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
05/07/2016 | 22:02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
30/06/2016 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 20:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 19:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:25 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
24/06/2016 | 14:23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |